Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Axim Biotechnologies receives patent for its purification and extraction methods of THC from cannabis

Tuesday, June 19, 2018 12:57
% of readers think this story is Fact. Add your two cents.

Axim Biotechnologies Inc (OTCQB:AXIM) has received a US patent for its method of purification and extraction of THC from medicinal cannabis.

The cannabinoid research and development firm’s process produces pure THC molecules that can be used as the active ingredient in pharmaceuticals.

READ: WeedMD to supply cannabidiol for new research looking at liver disease treatments

The biotech uses the method to extract THC for use in its MedChew RX program, a controlled-release chewing gum that can treat pain and spasticity in patients with multiple sclerosis.

“In our industry it is not only research and trials that enable companies to bring medications to market, but a consistent supply of pure molecules is necessary to achieve FDA compliance,” said CEO George E. Anastassov in a statement.

An estimated 2.3 million people are living with multiple sclerosis, according to the National MS Society.

Shares of the New York-based company fell slightly to US$3.20 in Tuesday afternoon trading.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories


Top Global

Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.